880 Winter Street
Paul Sohmer, M.D.
President & CEO
BG Medicine, Inc.
BG Medicine (NASDAQ: BGMD) is a publicly traded developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.
Noubar Afeyan and Harry Wilcox are on the Board of Directors.